Does ETOPOSIDE Cause Disseminated intravascular coagulation? 186 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Disseminated intravascular coagulation have been filed in association with ETOPOSIDE (Avopef). This represents 0.4% of all adverse event reports for ETOPOSIDE.
186
Reports of Disseminated intravascular coagulation with ETOPOSIDE
0.4%
of all ETOPOSIDE reports
119
Deaths
93
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From ETOPOSIDE?
Of the 186 reports, 119 (64.0%) resulted in death, 93 (50.0%) required hospitalization, and 38 (20.4%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 186 reports have been filed with the FAERS database.
What Other Side Effects Does ETOPOSIDE Cause?
Off label use (6,495)
Febrile neutropenia (5,966)
Disease progression (3,776)
Drug ineffective (3,687)
Neutropenia (3,641)
Thrombocytopenia (3,085)
Product use in unapproved indication (2,774)
Anaemia (2,586)
Pyrexia (2,453)
Sepsis (2,211)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which ETOPOSIDE Alternatives Have Lower Disseminated intravascular coagulation Risk?
ETOPOSIDE vs ETORICOXIB
ETOPOSIDE vs ETRASIMOD ARGININE
ETOPOSIDE vs ETRAVIRINE
ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL
ETOPOSIDE vs EVEROLIMUS